Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 70735-79-4 | MDL No. : | MFCD06252058 |
Formula : | C9H7NO3 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | FZAQRVWPQCXSPC-UHFFFAOYSA-N |
M.W : | 177.16 | Pubchem ID : | 9989779 |
Synonyms : |
|
Num. heavy atoms : | 13 |
Num. arom. heavy atoms : | 9 |
Fraction Csp3 : | 0.11 |
Num. rotatable bonds : | 1 |
Num. H-bond acceptors : | 3.0 |
Num. H-bond donors : | 1.0 |
Molar Refractivity : | 47.03 |
TPSA : | 63.07 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | Yes |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -6.8 cm/s |
Log Po/w (iLOGP) : | 1.46 |
Log Po/w (XLOGP3) : | 0.82 |
Log Po/w (WLOGP) : | 1.32 |
Log Po/w (MLOGP) : | 0.55 |
Log Po/w (SILICOS-IT) : | 2.31 |
Consensus Log Po/w : | 1.29 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 1.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -1.9 |
Solubility : | 2.22 mg/ml ; 0.0126 mol/l |
Class : | Very soluble |
Log S (Ali) : | -1.73 |
Solubility : | 3.32 mg/ml ; 0.0188 mol/l |
Class : | Very soluble |
Log S (SILICOS-IT) : | -3.15 |
Solubility : | 0.124 mg/ml ; 0.0007 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 0.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 2.34 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302-H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
[ 54903-16-1 ]
2-Oxo-2,3-dihydrobenzo[d]oxazole-6-carboxylic acid
Similarity: 0.86
[ 306937-12-2 ]
3-((tert-Butoxycarbonyl)amino)-4-methoxybenzoic acid
Similarity: 0.82
[ 256935-69-0 ]
3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-4-methoxybenzoic acid
Similarity: 0.80
[ 81282-60-2 ]
7-Aminobenzo[d]oxazol-2(3H)-one
Similarity: 0.77
[ 855300-09-3 ]
3-Acetylphenyl ethyl(methyl)carbamate
Similarity: 0.75
[ 855300-09-3 ]
3-Acetylphenyl ethyl(methyl)carbamate
Similarity: 0.75
[ 79537-70-5 ]
tert-Butyl (3-acetylphenyl)carbamate
Similarity: 0.74
[ 42465-54-3 ]
1-(2-Amino-3-methoxyphenyl)ethanone
Similarity: 0.74
[ 157014-41-0 ]
Benzyl (4-(2-bromoacetyl)phenyl)carbamate
Similarity: 0.72
[ 54903-16-1 ]
2-Oxo-2,3-dihydrobenzo[d]oxazole-6-carboxylic acid
Similarity: 0.86
[ 81282-60-2 ]
7-Aminobenzo[d]oxazol-2(3H)-one
Similarity: 0.77
[ 13451-79-1 ]
5-Fluorobenzo[d]oxazol-2(3H)-one
Similarity: 0.72
[ 871367-14-5 ]
7-Bromobenzo[d]oxazol-2(3H)-one
Similarity: 0.69
[ 162045-54-7 ]
3-(Piperidin-4-yl)benzo[d]oxazol-2(3H)-one hydrochloride
Similarity: 0.67